Skip to main content
OpenTrials

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

351 public trials 65 recruiting studies
Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

NCT05489783

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Glioma, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

NCT06502171

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Childrens of Alabama Birmingham, Alabama, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions
22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations
  • Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada
  • University of Alberta-Glenrose Edmonton, Alberta, Canada
  • Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details

Related conditions